Cyfuse Biomedical KK (TSE:4892) Short-Term Debt & Capital Lease Obligation : 円568.00 Mil (As of Dec. 2023)

View and export this data going back to 2022. Start your Free Trial

What is Cyfuse Biomedical KK Short-Term Debt & Capital Lease Obligation?

Short-Term Debt & Capital Lease Obligation is the portion of a company's debt and capital lease obligation that need to be paid within the next 12 months. It equals Short-Term Debt plus Short-Term Capital Lease Obligation. This gives investors an idea of how much money the company needs to pay down for the principle of its debt. Cyfuse Biomedical KK's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was 円568.00 Mil.

Long-Term Debt & Capital Lease Obligation is the debt and capital lease obligation due more than 12 months in the future. Cyfuse Biomedical KK's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was 円345.00 Mil.

Cyfuse Biomedical KK Short-Term Debt & Capital Lease Obligation Historical Data

The historical data trend for Cyfuse Biomedical KK's Short-Term Debt & Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cyfuse Biomedical KK Short-Term Debt & Capital Lease Obligation Chart

Cyfuse Biomedical KK Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Short-Term Debt & Capital Lease Obligation

89.56

209.24

545.14

568.00

Cyfuse Biomedical KK Quarterly Data
	Dec20	Dec21	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Short-Term Debt & Capital Lease Obligation	Get a 7-Day Free Trial				545.14	522.58	500.01	470.23	568.00

Cyfuse Biomedical KK Short-Term Debt & Capital Lease Obligation Calculation

This is the portion of a company's debt and capital lease obligation that need to be paid within the next 12 months. It equals Short-Term Debt plus Short-Term Capital Lease Obligation. This gives investors an idea of how much money the company needs to pay down for the principle of its debt.

In the notes to balance sheet in annual (10-K) or quarterly (10-Q) reports, companies usually break down the details of the debt, their due dates, the interest rates etc.

Be Aware

Stay away from companies that roll over the debt e.g. Bear Stearns

When investing in financial institutions, Buffett shies from those who are bigger borrowers of short term than long term debt.

His favorite Wells Fargo has 57 cents short term debt for every dollar of long term

Aggressive banks (like Bank of America) has $2.09 short term for every dollar long term

Cyfuse Biomedical KK Short-Term Debt & Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Cyfuse Biomedical KK's Short-Term Debt & Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Cyfuse Biomedical KK (TSE:4892) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cyfuse Biomedical KK (TSE:4892) » Definitions » Short-Term Debt & Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

N/A

Address

3-5-27, Mita, West Wing-1st Floor. Sumitomo Fudosan Mita Twin Building, Minato-ku, Tokyo, JPN

Website

https://www.cyfusebio.com

Cyfuse Biomedical KK is engaged in the development, manufacturing, and sales of regenerative medicine related products.

Cyfuse Biomedical KK (TSE:4892) Headlines

No Headlines